Pharmacovigilance Europe 2025
“INNOVATION AND INTEGRATION: ADVANCING GLOBAL PHARMACOVIGILANCE IN THE DIGITAL AGE”
2x DAYS POWER PACKED CONFERENCE
13th Annual International Conference And Exhibition In Pharmacovigilance, Regulatory Affairs, Risk Management And Clinical Trials
World’s Leading Pharmacovigilance Conference & Exhibition
21-22 May 2025 | London, UK
Welcome to
Pharmacovigilance Europe Congress 2025
After witnessing outstanding success in our previous Pharmacovigilance conferences, Pharmacovigilance Europe 2025 will gather the top notch Industry experts from Pharma/Biotech and Clinical Research Organisations from over 15 countries.
Why To Attend This Conference?
- Listen to the the top notch Pharma/Biotech Industry pioneers who will deliver the latest cutting edge information.
- A fantastic opportunity to network with the top notch Pharma/Biotech Industry pioneers during the networking sessions.
- Speak out sessions and Panel discussions will provide a great opportunity to ask questions from the expert and find out feasible solutions.
Connect – Communicate – Collaborate At The 13th International Pharmacovigilance Europe Congress!
Current Market Of Global Pharmacovigilance
Global Pharmacovigilance Market to reach $15 Billion in 2028
Global Pharmaceutical Market Value $1.5 Trillion
Come and Update with the expanding Global Pharmaceutical Industry and increase awareness on the significant and essential need of Global Pharmacovigilance.
PV EUROPE 2025 London, UK
2025 SPEAKERS
Come & Network with the International PV Leaders
Erika Barbarosie
Gilead Sciences | Ireland
Tahira Jan
MHRA | UK
Michael Bean
Johnson & Johnson
Michael Von Forstner
Sobi | Switzerland
Mateja Pranjić
GSK | UK
Bertrand Sailley
Takeda | Switzerland
Mircea Ciuca
Organon| Switzerland
Emanuel Lohrmann
OTSUKA | Germany
Pav Rishiraj
IPSEN | UK
Julia Appelskog
NOVAVAX INC | Sweden
Yvonne Nanciu
BAYER | Germany
Petar Gjorgiev
Regeneron | UK
Chetan Shatapathy
AstraZeneca | UK
International Companies Attending PV Europe
WHO SHOULD ATTEND
Pharmacovigilance Europe Congress attracts senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates includes VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following.
Pharmacovigilance Risk Management
Drug Safety Pharmacoepidemiology
Drug Research & Development Clinical Pharmacology
Clinical Safety Information And Clinical Data Management
Medical Product Safety Assessment Clinical Research & Safety
Data Analysis Information Technology
Medical Information Health Outcomes
Sales And Marketing Clinical Trials & CRO’s
Contract Manufacturing
WHY ATTEND PHARMACOVIGILANCE EUROPE?
A Global Event In Pharmacovigilance
Ensuring Pharmacovigilance For Global Public Health
20+ Expert Speakers From Around The World
100’S Pharma/ Biotech Professionals From Over 50 Countries
Bringing Together The Key Decision Makers Under One Roof
Over 10 Hours Of Dedicated Networking And Interactive Sessions
Trusted hands behind us
DOWNLOAD THE BROCHURE
Testimonials
Pharmacovigilance Europe Congress is an excellent platform for communication.
Vice President
Merck
Graviton did an excellent job by bringing so many busy Pharmacovigilance professionals together in a room who stayed throughout the day is a testimony to how interesting the event was. Also it has been very educational and informative.
Vice President
Ipsen BioPharma
We are sponsoring for the 2nd time this year and it’s been absolutely brilliant. We had so many people visiting our booth. The topics discussed have been “Hot off the Press”.
EXHIBITOR
WOLTERS KLUWER
We are sponsoring for the 2nd time this year and it’s been absolutely brilliant. We had so many people visiting our booth. The topics discussed have been “Hot off the Press”.
Drug Safety Director
ICON Plc
International Delegate Registrations From Across The Globe
JOIN US IN AMERICA